GPCR — Structure Therapeutics Inc. | XLV Holdings | StockAdder

(GPCR)

Structure Therapeutics Inc.

Live chart and latest GPCR stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

GPCR News

Structure Therapeutics (NASDAQ: GPCR) appoints Matthew Lang as COO and General Counsel

Apr 15, 2026 Yahoo Finance

Assessing Structure Therapeutics (GPCR) Valuation After Recent Share Price Weakness

Apr 9, 2026 Stock Titan

Metsera legal chief joins Structure as COO ahead of Phase 3

Apr 14, 2026 Seeking Alpha

Structure Therapeutics: A High-Risk, High-Reward Bet On The Next GLP-1 Blockbuster (GPCR)

Mar 27, 2026 simplywall.st

Assessing Structure Therapeutics (GPCR) Valuation After Recent Share Price Volatility

Mar 21, 2026 Yahoo Finance

Structure Therapeutics (GPCR) Gained from Favorable Clinical Data

Feb 19, 2026 Seeking Alpha

Structure Therapeutics: The Oral Obesity Inflection, Best-In-Class Efficacy Meets Biased-Agonism Safety Moat

Apr 8, 2026 Yahoo Finance

Structure Therapeutics Inc. (GPCR) Has Gained Over 130% in 3 Months. Here is Why

Jan 15, 2026 Stock Titan

Structure Therapeutics (NASDAQ: GPCR) awards new options and RSUs

Mar 23, 2026 Yahoo Finance

NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now?

Mar 23, 2026 Yahoo Finance

Why Structure Therapeutics (GPCR) Is Up 23.2% After Aleniglipron Milestone And $748 Million Raise – And What's Next

Jan 14, 2026 Yahoo Finance

Assessing Structure Therapeutics (GPCR) Valuation After Positive Phase 2 Data And Large Capital Raise

Jan 14, 2026 Yahoo Finance

GPCR Stock Soars 102% on Strong Phase II Obesity Data for Aleniglipron

Dec 9, 2025 Yahoo Finance

Jim Cramer on Structure Therapeutics: “I Don’t Want to Touch It”

Jan 16, 2026 Yahoo Finance

Structure Therapeutics (GPCR): Assessing Valuation as ACCESS Obesity Trial Readout Draws Investor Focus